People should be working on funding proposals for Bio-X risk mitigation policies, such as greater international coordination, better health monitoring systems, investment in non-disease specific symptomatic surveillance, and similar. These are likely to be far easier to fund in 3-6 months, as a huge pool of money is allocated to work on fixing the next pandemic.
Could you be more specific or provide an example?
People should be working on funding proposals for Bio-X risk mitigation policies, such as greater international coordination, better health monitoring systems, investment in non-disease specific symptomatic surveillance, and similar. These are likely to be far easier to fund in 3-6 months, as a huge pool of money is allocated to work on fixing the next pandemic.